Heart surgery study tests smarter blood transfusion strategy

NCT ID NCT02963883

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at two different methods for deciding when to give red blood cell transfusions to patients recovering from heart surgery. One method used a standard hemoglobin level threshold, while the other used a measure of oxygen in the blood (central venous oxygen saturation) to guide decisions. The goal was to see if the oxygen-based approach could reduce the number of patients receiving transfusions and improve safety. The study involved 160 adults undergoing planned heart surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a more personalized transfusion strategy that reduces unnecessary transfusions and improves patient outcomes after heart surgery.
What could go wrong: This is a completed early-stage study with 160 patients, so results may not apply to all heart surgery patients. The approach may not reduce complications or could miss cases where transfusion is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY

Contacts and locations

Show contact details

Locations

CHU Amiens Picardie

Amiens, 80054, France
Caen

Caen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.